MetLife Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,671	Closed	-$14K	–	2786
2021 Q4	$14K	Sell	1,671 -10,976	-87%	-$91.7K	﹤0.01%	2490
2021 Q3	$94K	Buy	+12,647	New	+$94K	﹤0.01%	2466
2018 Q2	–	Sell	-7,132	Closed	-$159K	–	2238
2018 Q1	$159K	Buy	+7,132	New	+$159K	﹤0.01%	2009